<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-10-07" version="195">
<accession>P49715</accession>
<accession>A7LNP2</accession>
<accession>P78319</accession>
<accession>Q05CA4</accession>
<name>CEBPA_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="24">CCAAT/enhancer-binding protein alpha</fullName>
<shortName evidence="24">C/EBP alpha</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary" evidence="24">CEBPA</name>
<name type="synonym" evidence="24">CEBP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Biochem. Biophys. Res. Commun." volume="215" first="106" last="113">
<title>Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein alpha (C/EBP alpha).</title>
<authorList>
<person name="Antonson P."/>
<person name="Xanthopoulos K.G."/>
</authorList>
<dbReference type="PubMed" id="7575576"/>
<dbReference type="DOI" id="10.1006/bbrc.1995.2439"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Umbilical cord</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Biol. Chem. Hoppe-Seyler" volume="378" first="373" last="379">
<title>Transcription factor C/EBP-alpha: novel sites of expression and cloning of the human gene.</title>
<authorList>
<person name="Swart G.W.M."/>
<person name="van Groningen J.J.M."/>
<person name="van Ruissen F."/>
<person name="Bergers M."/>
<person name="Schalwijk J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2007-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-133</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="2858" last="2865">
<title>Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.</title>
<authorList>
<person name="Choi B.H."/>
<person name="Park G.T."/>
<person name="Rho H.M."/>
</authorList>
<dbReference type="PubMed" id="9915821"/>
<dbReference type="DOI" id="10.1074/jbc.274.5.2858"/>
</citation>
<scope>INTERACTION WITH HBV PROTEIN X (MICROBIAL INFECTION)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="J. Cell Biol." volume="148" first="1165" last="1176">
<title>Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors.</title>
<authorList>
<person name="Aho S."/>
<person name="Buisson M."/>
<person name="Pajunen T."/>
<person name="Ryoo Y.W."/>
<person name="Giot J.-F."/>
<person name="Gruffat H."/>
<person name="Sergeant A."/>
<person name="Uitto J."/>
</authorList>
<dbReference type="PubMed" id="10725330"/>
<dbReference type="DOI" id="10.1083/jcb.148.6.1165"/>
</citation>
<scope>INTERACTION WITH UBN1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Genes Chromosomes Cancer" volume="37" first="72" last="78">
<title>Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.</title>
<authorList>
<person name="Snaddon J."/>
<person name="Smith M.L."/>
<person name="Neat M."/>
<person name="Cambal-Parrales M."/>
<person name="Dixon-McIver A."/>
<person name="Arch R."/>
<person name="Amess J.A."/>
<person name="Rohatiner A.Z."/>
<person name="Lister T.A."/>
<person name="Fitzgibbon J."/>
</authorList>
<dbReference type="PubMed" id="12661007"/>
<dbReference type="DOI" id="10.1002/gcc.10185"/>
</citation>
<scope>INVOLVEMENT IN AML</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="912" last="925">
<title>Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity.</title>
<authorList>
<person name="Wang G.L."/>
<person name="Iakova P."/>
<person name="Wilde M."/>
<person name="Awad S."/>
<person name="Timchenko N.A."/>
</authorList>
<dbReference type="PubMed" id="15107404"/>
<dbReference type="DOI" id="10.1101/gad.1183304"/>
</citation>
<scope>INTERACTION WITH CDK2; CDK4; E2F4; RB1 AND SMARCA2</scope>
<scope>PHOSPHORYLATION AT SER-190</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7353" last="7358">
<title>The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.</title>
<authorList>
<person name="Muller C."/>
<person name="Calkhoven C.F."/>
<person name="Sha X."/>
<person name="Leutz A."/>
</authorList>
<dbReference type="PubMed" id="14660596"/>
<dbReference type="DOI" id="10.1074/jbc.m312709200"/>
</citation>
<scope>FUNCTION (ISOFORMS 1 AND 3)</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="N. Engl. J. Med." volume="351" first="2403" last="2407">
<title>Mutation of CEBPA in familial acute myeloid leukemia.</title>
<authorList>
<person name="Smith M.L."/>
<person name="Cavenagh J.D."/>
<person name="Lister T.A."/>
<person name="Fitzgibbon J."/>
</authorList>
<dbReference type="PubMed" id="15575056"/>
<dbReference type="DOI" id="10.1056/nejmoa041331"/>
</citation>
<scope>INVOLVEMENT IN AML</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2010" name="Blood" volume="116" first="1321" last="1328">
<title>Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.</title>
<authorList>
<person name="Dedhia P.H."/>
<person name="Keeshan K."/>
<person name="Uljon S."/>
<person name="Xu L."/>
<person name="Vega M.E."/>
<person name="Shestova O."/>
<person name="Zaks-Zilberman M."/>
<person name="Romany C."/>
<person name="Blacklow S.C."/>
<person name="Pear W.S."/>
</authorList>
<dbReference type="PubMed" id="20410507"/>
<dbReference type="DOI" id="10.1182/blood-2009-07-229450"/>
</citation>
<scope>INTERACTION WITH TRIB1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="897" last="909">
<title>Nucleolar retention of a translational C/EBPalpha isoform stimulates rDNA transcription and cell size.</title>
<authorList>
<person name="Muller C."/>
<person name="Bremer A."/>
<person name="Schreiber S."/>
<person name="Eichwald S."/>
<person name="Calkhoven C.F."/>
</authorList>
<dbReference type="PubMed" id="20075868"/>
<dbReference type="DOI" id="10.1038/emboj.2009.404"/>
</citation>
<scope>FUNCTION (ISOFORM 4)</scope>
<scope>ALTERNATIVE INITIATION</scope>
<scope>IDENTIFICATION OF NON-CANONICAL INITIATION CODON</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 4)</scope>
<scope>INTERACTION WITH NPM1; TAF1A AND UBTF</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2293" last="2304">
<title>Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes.</title>
<authorList>
<person name="Zaragoza K."/>
<person name="Begay V."/>
<person name="Schuetz A."/>
<person name="Heinemann U."/>
<person name="Leutz A."/>
</authorList>
<dbReference type="PubMed" id="20176812"/>
<dbReference type="DOI" id="10.1128/mcb.01619-09"/>
</citation>
<scope>INTERACTION WITH TFDP1; TFDP2 AND E2F1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2015" name="Structure" volume="23" first="2111" last="2121">
<title>Molecular mechanism of CCAAT-enhancer binding protein recruitment by the TRIB1 pseudokinase.</title>
<authorList>
<person name="Murphy J.M."/>
<person name="Nakatani Y."/>
<person name="Jamieson S.A."/>
<person name="Dai W."/>
<person name="Lucet I.S."/>
<person name="Mace P.D."/>
</authorList>
<dbReference type="PubMed" id="26455797"/>
<dbReference type="DOI" id="10.1016/j.str.2015.08.017"/>
</citation>
<scope>INTERACTION WITH TRIB1</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF ILE-55; GLU-57; HIS-58; GLU-59; SER-61; ILE-62; ASP-63; ILE-64; SER-65; TYR-67; ILE-68 AND ASP-69</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2016" name="PLoS Genet." volume="12" first="E1006474" last="E1006474">
<title>Comparative Transcriptomic and Epigenomic Analyses Reveal New Regulators of Murine Brown Adipogenesis.</title>
<authorList>
<person name="Brunmeir R."/>
<person name="Wu J."/>
<person name="Peng X."/>
<person name="Kim S.Y."/>
<person name="Julien S.G."/>
<person name="Zhang Q."/>
<person name="Xie W."/>
<person name="Xu F."/>
</authorList>
<dbReference type="PubMed" id="27923061"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1006474"/>
</citation>
<scope>INTERACTION WITH SIX1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2016" name="Structure" volume="24" first="687" last="696">
<title>Structural basis for substrate selectivity of the E3 ligase COP1.</title>
<authorList>
<person name="Uljon S."/>
<person name="Xu X."/>
<person name="Durzynska I."/>
<person name="Stein S."/>
<person name="Adelmant G."/>
<person name="Marto J.A."/>
<person name="Pear W.S."/>
<person name="Blacklow S.C."/>
</authorList>
<dbReference type="PubMed" id="27041596"/>
<dbReference type="DOI" id="10.1016/j.str.2016.03.002"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Nat. Genet." volume="27" first="263" last="270">
<title>Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.</title>
<authorList>
<person name="Pabst T."/>
<person name="Mueller B.U."/>
<person name="Zhang P."/>
<person name="Radomska H.S."/>
<person name="Narravula S."/>
<person name="Schnittger S."/>
<person name="Behre G."/>
<person name="Hiddemann W."/>
<person name="Tenen D.G."/>
</authorList>
<dbReference type="PubMed" id="11242107"/>
<dbReference type="DOI" id="10.1038/85820"/>
</citation>
<scope>VARIANTS AML LEU-84 AND LYS-312 INS</scope>
<scope>CHARACTERIZATION OF VARIANTS AML LEU-84 AND LYS-312 INS</scope>
<scope>INVOLVEMENT IN AML</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ALTERNATIVE TRANSLATIONAL INITIATION</scope>
<scope>DNA-BINDING</scope>
</reference>
<comment type="function">
<text evidence="5 6 9 11">Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5'-T[TG]NNGNAA[TG]-3' acting as an activator on distinct target genes (PubMed:11242107). During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung (By similarity). Necessary for terminal adipocyte differentiation, is required for postnatal maintenance of systemic energy homeostasis and lipid storage (By similarity). To regulate these different processes at the proper moment and tissue, interplays with other transcription factors and modulators. Downregulates the expression of genes that maintain cells in an undifferentiated and proliferative state through E2F1 repression, which is critical for its ability to induce adipocyte and granulocyte terminal differentiation. Reciprocally E2F1 blocks adipocyte differentiation by binding to specific promoters and repressing CEBPA binding to its target gene promoters. Proliferation arrest also depends on a functional binding to SWI/SNF complex (PubMed:14660596). In liver, regulates gluconeogenesis and lipogenesis through different mechanisms. To regulate gluconeogenesis, functionally cooperates with FOXO1 binding to IRE-controlled promoters and regulating the expression of target genes such as PCK1 or G6PC. To modulate lipogenesis, interacts and transcriptionally synergizes with SREBF1 in promoter activation of specific lipogenic target genes such as ACAS2. In adipose tissue, seems to act as FOXO1 coactivator accessing to ADIPOQ promoter through FOXO1 binding sites (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform 3</molecule>
<text evidence="5 6 11">Can act as dominant-negative. Binds DNA and have transctivation activity, even if much less efficiently than isoform 2. Does not inhibit cell proliferation (PubMed:14660596).</text>
</comment>
<comment type="function">
<molecule>Isoform 4</molecule>
<text evidence="14">Directly and specifically enhances ribosomal DNA transcription interacting with RNA polymerase I-specific cofactors and inducing histone acetylation.</text>
</comment>
<comment type="subunit">
<text evidence="5 6 8 12 14 15 16 17 18">Binds DNA as a homodimer and as a heterodimer. Can form stable heterodimers with CEBPB, CEBPD, CEBPE and CEBPG (By similarity). Interacts with PRDM16 (By similarity). Interacts with UBN1 (PubMed:10725330). Interacts with ZNF638; this interaction increases transcriptional activation (By similarity). Interacts with the complex TFDP2:E2F1; the interaction prevents CEBPA binding to target gene promoters and represses its transcriptional activity (PubMed:20176812). Interacts with RB1 (PubMed:15107404). Interacts (when phosphorylated at SER-190) with CDK2, CDK4, E2F4 and SMARCA2 (PubMed:15107404). Interacts with SREBPF1 (By similarity). Interacts with FOXO1 (via the Fork-head domain); the interaction increases when FOXO1 is deacetylated (By similarity). Interacts with SIX1 (PubMed:27923061). Interacts (via recognition sequence) with TRIB1 (PubMed:20410507, PubMed:26455797).</text>
</comment>
<comment type="subunit">
<molecule>Isoform 1</molecule>
<text evidence="14">Interacts with TAF1A and UBTF.</text>
</comment>
<comment type="subunit">
<molecule>Isoform 4</molecule>
<text evidence="14">Interacts with TAF1A and UBTF (PubMed:20075868). Interacts with NPM1 (PubMed:20075868).</text>
</comment>
<comment type="subunit">
<text evidence="19">(Microbial infection) Interacts with HBV protein X.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-492498">
<id>P18848</id>
<label>ATF4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-8514176">
<id>P47902</id>
<label>CDX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-969696">
<id>P17676</id>
<label>CEBPB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-7962058">
<id>P49716</id>
<label>CEBPD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-740209">
<id>P53567</id>
<label>CEBPG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-742651">
<id>P35638</id>
<label>DDIT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-8800907">
<id>P24001-2</id>
<label>IL32</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-355676">
<id>P09874</id>
<label>PARP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-7028618">
<id>P03122</id>
<label>E2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1172054">
<id>P49715</id>
</interactant>
<interactant intactId="EBI-7136851">
<id>P06422</id>
<label>E2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16180754">
<id>P49715-1</id>
</interactant>
<interactant intactId="EBI-16180744">
<id>Q96RU8-1</id>
<label>TRIB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="9">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 4</molecule>
<subcellularLocation>
<location evidence="14">Nucleus</location>
<location evidence="14">Nucleolus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative initiation"/>
<isoform>
<id>P49715-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P49715-2</id>
<name>2</name>
<name evidence="20">C/EBPalpha-p42</name>
<sequence type="described" ref="VSP_057548"/>
</isoform>
<isoform>
<id>P49715-3</id>
<name>3</name>
<name evidence="20">C/EBPalpha-p30</name>
<sequence type="described" ref="VSP_057547"/>
</isoform>
<isoform>
<id>P49715-4</id>
<name>4</name>
<name evidence="21">extended-C/EBPalpha</name>
<sequence type="described" ref="VSP_057607"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="17">The recognition sequence (54-72) is required for interaction with TRIB1.</text>
</comment>
<comment type="PTM">
<text evidence="6">Phosphorylation at Ser-190 is required for interaction with CDK2, CDK4 and SWI/SNF complex leading to cell cycle inhibition. Dephosphorylated at Ser-190 by protein phosphatase 2A (PP2A) through PI3K/AKT signaling pathway regulation (PubMed:15107404). Phosphorylation at Thr-226 and Thr-230 by GSK3 is constitutive in adipose tissue and lung. In liver, both Thr-226 and Thr-230 are phosphorylated only during feeding but not during fasting. Phosphorylation of the GSK3 consensus sites selectively decreases transactivation activity on IRE-controlled promoters.</text>
</comment>
<comment type="PTM">
<text evidence="5">Sumoylated, sumoylation blocks the inhibitory effect on cell proliferation by disrupting the interaction with SMARCA2.</text>
</comment>
<comment type="PTM">
<text evidence="22">Ubiquitinated by COP1 upon interaction with TRIB1.</text>
</comment>
<comment type="disease" evidence="9 10 13">
<disease id="DI-01171">
<name>Leukemia, acute myelogenous</name>
<acronym>AML</acronym>
<description>A subtype of acute leukemia, a cancer of the white blood cells. AML is a malignant disease of bone marrow characterized by maturational arrest of hematopoietic precursors at an early stage of development. Clonal expansion of myeloid blasts occurs in bone marrow, blood, and other tissue. Myelogenous leukemias develop from changes in cells that normally produce neutrophils, basophils, eosinophils and monocytes.</description>
<dbReference type="MIM" id="601626"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the bZIP family. C/EBP subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CEBPAID40050ch19q13.html"/>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/cebpa/"/>
</comment>
<dbReference type="EMBL" id="U34070">
<property type="protein sequence ID" value="AAC50235.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="Y11525">
<property type="protein sequence ID" value="CAA72289.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU048234">
<property type="protein sequence ID" value="ABS82765.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008738">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC027902">
<property type="protein sequence ID" value="AAH27902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54243.1">
<molecule id="P49715-1"/>
</dbReference>
<dbReference type="PIR" id="JC4311">
<property type="entry name" value="JC4311"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001272758.1">
<molecule id="P49715-3"/>
<property type="nucleotide sequence ID" value="NM_001285829.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001274353.1">
<molecule id="P49715-4"/>
<property type="nucleotide sequence ID" value="NM_001287424.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001274364.1">
<molecule id="P49715-2"/>
<property type="nucleotide sequence ID" value="NM_001287435.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004355.2">
<molecule id="P49715-1"/>
<property type="nucleotide sequence ID" value="NM_004364.4"/>
</dbReference>
<dbReference type="PDB" id="6DC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=51-75"/>
</dbReference>
<dbReference type="PDBsum" id="6DC0"/>
<dbReference type="SMR" id="P49715"/>
<dbReference type="BioGRID" id="107479">
<property type="interactions" value="103"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-69">
<property type="entry name" value="CHOP-C/EBPalpha complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-71">
<property type="entry name" value="C/EBPalpha complex"/>
</dbReference>
<dbReference type="CORUM" id="P49715"/>
<dbReference type="DIP" id="DIP-37882N"/>
<dbReference type="ELM" id="P49715"/>
<dbReference type="IntAct" id="P49715">
<property type="interactions" value="24"/>
</dbReference>
<dbReference type="MINT" id="P49715"/>
<dbReference type="STRING" id="9606.ENSP00000427514"/>
<dbReference type="iPTMnet" id="P49715"/>
<dbReference type="PhosphoSitePlus" id="P49715"/>
<dbReference type="BioMuta" id="CEBPA"/>
<dbReference type="DMDM" id="166898082"/>
<dbReference type="EPD" id="P49715"/>
<dbReference type="jPOST" id="P49715"/>
<dbReference type="MassIVE" id="P49715"/>
<dbReference type="MaxQB" id="P49715"/>
<dbReference type="PaxDb" id="P49715"/>
<dbReference type="PeptideAtlas" id="P49715"/>
<dbReference type="PRIDE" id="P49715"/>
<dbReference type="ProteomicsDB" id="56054"/>
<dbReference type="Antibodypedia" id="38083">
<property type="antibodies" value="679 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1050"/>
<dbReference type="Ensembl" id="ENST00000498907">
<molecule id="P49715-1"/>
<property type="protein sequence ID" value="ENSP00000427514"/>
<property type="gene ID" value="ENSG00000245848"/>
</dbReference>
<dbReference type="GeneID" id="1050"/>
<dbReference type="KEGG" id="hsa:1050"/>
<dbReference type="UCSC" id="uc002nun.4">
<molecule id="P49715-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1050"/>
<dbReference type="DisGeNET" id="1050"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000245848.2"/>
<dbReference type="GeneCards" id="CEBPA"/>
<dbReference type="GeneReviews" id="CEBPA"/>
<dbReference type="HGNC" id="HGNC:1833">
<property type="gene designation" value="CEBPA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000245848">
<property type="expression patterns" value="Tissue enhanced (breast, liver)"/>
</dbReference>
<dbReference type="MalaCards" id="CEBPA"/>
<dbReference type="MIM" id="116897">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="601626">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P49715"/>
<dbReference type="OpenTargets" id="ENSG00000245848"/>
<dbReference type="Orphanet" id="319480">
<property type="disease" value="Acute myeloid leukemia with CEBPA somatic mutations"/>
</dbReference>
<dbReference type="Orphanet" id="102724">
<property type="disease" value="Acute myeloid leukemia with t(8;21)(q22;q22) translocation"/>
</dbReference>
<dbReference type="Orphanet" id="319465">
<property type="disease" value="Inherited acute myeloid leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26376"/>
<dbReference type="eggNOG" id="KOG3119">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000162646"/>
<dbReference type="HOGENOM" id="CLU_043327_2_0_1"/>
<dbReference type="InParanoid" id="P49715"/>
<dbReference type="KO" id="K09055"/>
<dbReference type="OMA" id="QYQIAHC"/>
<dbReference type="OrthoDB" id="1284308at2759"/>
<dbReference type="PhylomeDB" id="P49715"/>
<dbReference type="TreeFam" id="TF105008"/>
<dbReference type="PathwayCommons" id="P49715"/>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="SignaLink" id="P49715"/>
<dbReference type="SIGNOR" id="P49715"/>
<dbReference type="BioGRID-ORCS" id="1050">
<property type="hits" value="64 hits in 898 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CEBPA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CEBPA"/>
<dbReference type="GenomeRNAi" id="1050"/>
<dbReference type="Pharos" id="P49715">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P49715"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="P49715">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000245848">
<property type="expression patterns" value="Expressed in adipose tissue of abdominal region and 223 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P49715">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001163">
<property type="term" value="F:RNA polymerase I transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050873">
<property type="term" value="P:brown fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048469">
<property type="term" value="P:cell maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071285">
<property type="term" value="P:cellular response to lithium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008203">
<property type="term" value="P:cholesterol metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001892">
<property type="term" value="P:embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045444">
<property type="term" value="P:fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006091">
<property type="term" value="P:generation of precursor metabolites and energy"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030851">
<property type="term" value="P:granulocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048839">
<property type="term" value="P:inner ear development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070102">
<property type="term" value="P:interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055088">
<property type="term" value="P:lipid homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001889">
<property type="term" value="P:liver development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030225">
<property type="term" value="P:macrophage differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007005">
<property type="term" value="P:mitochondrion organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045736">
<property type="term" value="P:negative regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000144">
<property type="term" value="P:positive regulation of DNA-templated transcription, initiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045600">
<property type="term" value="P:positive regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043032">
<property type="term" value="P:positive regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045945">
<property type="term" value="P:positive regulation of transcription by RNA polymerase III"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006360">
<property type="term" value="P:transcription by RNA polymerase I"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000050">
<property type="term" value="P:urea cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0050872">
<property type="term" value="P:white fat cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR004827">
<property type="entry name" value="bZIP"/>
</dbReference>
<dbReference type="InterPro" id="IPR016468">
<property type="entry name" value="C/EBP_chordates"/>
</dbReference>
<dbReference type="Pfam" id="PF07716">
<property type="entry name" value="bZIP_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF005879">
<property type="entry name" value="CCAAT/enhancer-binding"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00338">
<property type="entry name" value="BRLZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50217">
<property type="entry name" value="BZIP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="CCAAT/enhancer-binding protein alpha" id="PRO_0000076613">
<location>
<begin position="1"/>
<end position="358"/>
</location>
</feature>
<feature type="domain" description="bZIP" evidence="7">
<location>
<begin position="282"/>
<end position="345"/>
</location>
</feature>
<feature type="DNA-binding region" evidence="5">
<location>
<begin position="285"/>
<end position="300"/>
</location>
</feature>
<feature type="region of interest" description="Required to repress E2F1:TFDP1-mediated transcription, to inhibit cell cycle and to induce adipocyte differentiation" evidence="5">
<location>
<begin position="1"/>
<end position="70"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with TRIB1" evidence="17">
<location>
<begin position="54"/>
<end position="72"/>
</location>
</feature>
<feature type="region of interest" description="Required to induce adipocyte differentiation" evidence="5">
<location>
<begin position="128"/>
<end position="204"/>
</location>
</feature>
<feature type="region of interest" description="Required to functionally cooperate with SREBF1 in promoter activation" evidence="6">
<location>
<begin position="182"/>
<end position="198"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with FOXO1" evidence="6">
<location>
<begin position="244"/>
<end position="358"/>
</location>
</feature>
<feature type="region of interest" description="Basic motif" evidence="7">
<location>
<begin position="286"/>
<end position="313"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper" evidence="7">
<location>
<begin position="317"/>
<end position="345"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="99"/>
<end position="104"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="183"/>
<end position="189"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="2">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="190"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3" evidence="6">
<location>
<position position="226"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3" evidence="6">
<location>
<position position="230"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3" evidence="6">
<location>
<position position="234"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="3 4">
<location>
<position position="161"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_057547">
<location>
<begin position="1"/>
<end position="119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_057548">
<location>
<begin position="1"/>
<end position="14"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_057607">
<original>M</original>
<variation>MRGRGRAGSPGGRRRRPAQAGGRRGSPCRENSNSPM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="sequence variant" description="In AML; no effect on expression; no effect on DNA-binding or transactivation activity; dbSNP:rs28931590." id="VAR_072677" evidence="9">
<original>H</original>
<variation>L</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In AML; nuclear; no effect on expression; loss of DNA-binding and transactivation activity." id="VAR_072678" evidence="9">
<original>Q</original>
<variation>QK</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>I</original>
<variation>A</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TRIB1." evidence="17">
<original>E</original>
<variation>T</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TRIB1." evidence="17">
<original>H</original>
<variation>D</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>E</original>
<variation>A</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>I</original>
<variation>A</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TRIB1." evidence="17">
<original>D</original>
<variation>A</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>I</original>
<variation>A</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TRIB1." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>Y</original>
<variation>A</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TRIB1." evidence="17">
<original>Y</original>
<variation>F</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased interaction with TRIB1." evidence="17">
<original>I</original>
<variation>A</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with TRIB1." evidence="17">
<original>D</original>
<variation>A</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50235." ref="1" evidence="23">
<original>AQ</original>
<variation>PK</variation>
<location>
<begin position="40"/>
<end position="41"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA72289." ref="2" evidence="23">
<original>VGPT</original>
<variation>WAH</variation>
<location>
<begin position="95"/>
<end position="98"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA72289." ref="2" evidence="23">
<original>L</original>
<variation>V</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA72289." ref="2" evidence="23">
<original>GPG</original>
<variation>ALA</variation>
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50235." ref="1" evidence="23">
<original>S</original>
<variation>T</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6DC0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P05554"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P53566"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00978"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10725330"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11242107"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12661007"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14660596"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15107404"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15575056"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20075868"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20176812"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20410507"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26455797"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27923061"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9915821"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11242107"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20075868"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="27041596"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1833"/>
</source>
</evidence>
<sequence length="358" mass="37561" checksum="574C0A049E25BCAC" modified="2008-02-05" version="3">MESADFYEAEPRPPMSSHLQSPPHAPSSAAFGFPRGAGPAQPPAPPAAPEPLGGICEHETSIDISAYIDPAAFNDEFLADLFQHSRQQEKAKAAVGPTGGGGGGDFDYPGAPAGPGGAVMPGGAHGPPPGYGCAAAGYLDGRLEPLYERVGAPALRPLVIKQEPREEDEAKQLALAGLFPYQPPPPPPPSHPHPHPPPAHLAAPHLQFQIAHCGQTTMHLQPGHPTPPPTPVPSPHPAPALGAAGLPGPGSALKGLGAAHPDLRASGGSGAGKAKKSVDKNSNEYRVRRERNNIAVRKSRDKAKQRNVETQQKVLELTSDNDRLRKRVEQLSRELDTLRGIFRQLPESSLVKAMGNCA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

